Laurent Greillier Selected Research

Laurent Greillier Research Topics

Disease

46	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2024 - 04/2004
42	Neoplasms (Cancer) 05/2024 - 01/2008
15	Malignant Mesothelioma 01/2022 - 11/2007
13	Lung Neoplasms (Lung Cancer) 05/2024 - 03/2012
11	Mesothelioma 02/2024 - 01/2008
7	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 04/2024 - 11/2017
6	Brain Neoplasms (Brain Tumor) 03/2024 - 11/2017
6	Neoplasm Metastasis (Metastasis) 11/2023 - 11/2010
3	Disease Progression 01/2023 - 12/2018
3	Thymoma (Thymic Carcinoma) 01/2022 - 01/2016
3	Neutropenia 01/2020 - 11/2017
2	Frailty 12/2021 - 12/2020
2	Adenocarcinoma 11/2021 - 12/2014
2	Encephalitis (Encephalitis, Rasmussen) 01/2021 - 01/2019
2	Carcinoma (Carcinomatosis) 01/2021 - 11/2018
2	Febrile Neutropenia 01/2020 - 11/2017
2	Asthenia 01/2020 - 01/2019
2	Fatigue 01/2019 - 06/2017
2	Pleural Effusion (Pleural Effusions) 04/2016 - 01/2008
1	Autoimmune Diseases (Autoimmune Disease) 04/2024
1	Interstitial Lung Diseases (Interstitial Lung Disease) 04/2024
1	Microsatellite Instability 02/2024
1	Weight Loss (Weight Reduction) 05/2023
1	Oncogene Addiction 01/2023
1	Neuralgia (Stump Neuralgia) 01/2023
1	Cognitive Dysfunction 05/2022
1	COVID-19 01/2022
1	Malnutrition (Nutritional Deficiencies) 12/2021
1	Edema (Dropsy) 01/2021
1	Pneumonia (Pneumonitis) 01/2021
1	Heart Failure 01/2021
1	Thrombocytopenia (Thrombopenia) 01/2020
1	Sepsis (Septicemia) 01/2020
1	Peripheral Nervous System Diseases (PNS Diseases) 10/2019
1	Massive Hepatic Necrosis 01/2019
1	Adenocarcinoma of Lung 01/2019

Drug/Important Bio-Agent (IBA)

16	Pemetrexed (MTA)FDA Link 11/2023 - 03/2009
10	Cisplatin (Platino)FDA LinkGeneric 11/2023 - 04/2011
9	Immune Checkpoint InhibitorsIBA 05/2024 - 12/2018
9	Bevacizumab (Avastin)FDA Link 01/2023 - 04/2016
8	PlatinumIBA 05/2024 - 01/2019
8	pembrolizumabIBA 03/2024 - 11/2019
8	Biomarkers (Surrogate Marker)IBA 02/2024 - 01/2008
5	Carboplatin (JM8)FDA LinkGeneric 11/2023 - 01/2020
5	LigandsIBA 10/2023 - 01/2019
5	IpilimumabIBA 01/2022 - 03/2012
5	NivolumabIBA 01/2022 - 01/2019
4	B7-H1 AntigenIBA 05/2024 - 01/2019
4	atezolizumabIBA 11/2023 - 01/2019
4	AsbestosIBA 04/2016 - 01/2008
3	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2024 - 10/2023
3	Vinorelbine (Navelbine)FDA LinkGeneric 01/2022 - 07/2017
2	Proteins (Proteins, Gene)FDA Link 05/2024 - 01/2019
2	Immunoconjugates (Immunoconjugate)IBA 05/2024 - 01/2020
2	Gefitinib (Iressa)FDA Link 02/2024 - 06/2005
2	osimertinibIBA 02/2024 - 01/2019
2	ErbB Receptors (EGF Receptor)IBA 01/2024 - 01/2023
2	Tyrosine Kinase InhibitorsIBA 01/2023 - 02/2018
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2023 - 04/2016
2	Docetaxel (Taxotere)FDA Link 01/2022 - 11/2021
2	2- benzylidene- 3- (cyclohexylamino)- 2,3- dihydro- 1H- inden- 1- oneIBA 12/2021 - 12/2020
2	nintedanibIBA 11/2021 - 11/2017
2	Circulating Tumor DNAIBA 01/2021 - 11/2020
2	Topotecan (Hycamtin)FDA LinkGeneric 01/2021 - 01/2020
2	Surface Antigens (Surface Antigen)IBA 01/2020 - 01/2008
2	Sunitinib (Sutent)FDA Link 11/2016 - 01/2016
1	ParaffinIBA 02/2024
1	Formaldehyde (Formol)FDA Link 02/2024
1	Anti-Bacterial Agents (Antibiotics)IBA 10/2023
1	AntibodiesIBA 06/2023
1	Analgesics (Analgesic Drugs)IBA 01/2023
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2023
1	Cell-Free Nucleic AcidsIBA 10/2022
1	AmphiregulinIBA 01/2022
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2022
1	VaccinesIBA 01/2022
1	Trastuzumab (Herceptin)FDA Link 01/2022
1	pertuzumabIBA 01/2022
1	lenvatinibIBA 01/2022
1	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 12/2020
1	C-Reactive ProteinIBA 12/2020
1	Antineoplastic Agents (Antineoplastics)IBA 01/2020
1	Etoposide (VP 16)FDA LinkGeneric 01/2020
1	rovalpituzumab tesirineIBA 12/2019
1	lorlatinibIBA 12/2019
1	trametinibIBA 01/2019
1	alectinibIBA 01/2019
1	Anaplastic Lymphoma KinaseIBA 01/2019

Therapy/Procedure

27	Therapeutics 05/2024 - 11/2007
27	Drug Therapy (Chemotherapy) 05/2024 - 11/2007
6	Immunotherapy 04/2024 - 10/2020
5	Radiotherapy 01/2021 - 11/2007
3	Combination Drug Therapy (Combination Chemotherapy) 10/2023 - 01/2020
2	Chemoradiotherapy 01/2024 - 04/2018
2	Activities of Daily Living (ADL) 05/2022 - 01/2022
2	Precision Medicine 01/2021 - 12/2017
1	Home Nursing (Nursing, Home) 07/2021
1	Cryosurgery 01/2021
1	Ambulatory Care (Outpatient Care) 12/2020
1	Medication Reconciliation 01/2020